Selective internal radiation therapy in patients with progressive neuroendocrine liver metastases

Selective Internal Radiation Therapy: Quantifying Distal Penetration and Distribution of Resin and Glass Microspheres in a Surrogate Arterial Model

(2015) Shaphan R. Jernigan et al.   JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY

Pilot randomized trial of selective internal radiation therapy vs. chemoembolization in unresectable hepatocellular carcinoma

(2015) Frank T. Kolligs et al.   LIVER INTERNATIONAL

Role of hepatic intra-arterial therapies in metastatic neuroendocrine tumours (NET): guidelines from the NET-Liver-Metastases Consensus Conference

(2015) Andrew Kennedy et al.   HPB

Extrahepatic Disease Should Not Preclude Transarterial Chemoembolization for Metastatic Neuroendocrine Carcinoma

(2013) David Arrese et al.   ANNALS OF SURGICAL ONCOLOGY

Hepatic volume changes after lobar selective internal radiation therapy (SIRT) of hepatocellular carcinoma

(2013) J.M. Theysohn et al.   CLINICAL RADIOLOGY

Radioembolisation for liver metastases: Results from a prospective 151 patient multi-institutional phase II study

(2013) Al B. Benson et al.   EUROPEAN JOURNAL OF CANCER

Radioembolization for Treatment of Liver Metastases From Neuroendocrine Tumors

(2013) Junko Ozao-Choy et al.   PANCREAS

Radioembolization of Symptomatic, Unresectable Neuroendocrine Hepatic Metastases Using Yttrium-90 Microspheres

(2011) Philipp M. Paprottka et al.   CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY

Radioembolization for Neuroendocrine Liver Metastases: Safety, Imaging, and Long-Term Outcomes

(2011) Khairuddin Memon et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Radioembolization for Unresectable Neuroendocrine Hepatic Metastases Using Resin 90Y-Microspheres: Early Results in 148 Patients

(2010) Andrew S. Kennedy et al.   AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS

Radioembolization in the Treatment of Unresectable Liver Tumors

(2010) Douglas Coldwell et al.   AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS

Factors Predicting Response and Survival After Yttrium-90 Radioembolization of Unresectable Neuroendocrine Tumor Liver Metastases

(2010) Akshat Saxena et al.   ANNALS OF SURGERY

Radioembolization with yttrium microspheres for neuroendocrine tumour liver metastases

(2010) C. Q. Cao et al.   BRITISH JOURNAL OF SURGERY

Hepatic artery chemoembolization for the treatment of liver metastases from neuroendocrine tumors: a long-term follow-up in 123 patients

(2010) Xiang Da Dong et al.   MEDICAL ONCOLOGY

Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma

(2010) Riccardo Lencioni et al.   SEMINARS IN LIVER DISEASE

Liver Metastases of Neuroendocrine Tumors: Treatment With Hepatic Transarterial Chemotherapy Using Two Therapeutic Protocols

(2009) Thomas J. Vogl et al.   AMERICAN JOURNAL OF ROENTGENOLOGY

90Y Radioembolization for Metastatic Neuroendocrine Liver Tumors

(2008) Thomas K. Rhee et al.   ANNALS OF SURGERY

Radioembolization with selective internal radiation microspheres for neuroendocrine liver metastases

(2008) Julie King et al.   CANCER

Hepatic artery chemoinfusion with chemoembolization for neuroendocrine cancer with progressive hepatic metastases despite octreotide therapy

(2008) Dara Christante et al.   SURGERY